Hosted on MSN15d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the deal ...
China's WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to Merck for about $500 million. WuXi had previously said it was planning to sell some of its operations as the ...
WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)
WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...
“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in face of Biosecure
At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...
Wuxi Biologics Sells Vaccines Ireland Facility for $500M
Wuxi Biologics (Cayman) ( (HK:2269) ) has provided an announcement.
scmp.com15d
China’s WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom
China’s WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to US drug maker Merck & Co for about US$500 million, ahead of potential US legislation that would restrict ...
FiercePharma16d
In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics
In Ireland, WuXi Biologics has sold a new vaccine plant to Merck & Co. for €500 million ($521 million). The New Jersey company was a natural buyer of the facility as it was the lone client WuXi ...
WuXi Biologics: Buy Rating Supported by Strong Performance, Strategic Growth, and Increased Target Price
CMB International Securities analyst Jill Wu has maintained their bullish stance on WXIBF stock, giving a Buy rating on January 13.Stay Ahead ...
Yahoo Finance15d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...
Wall Street Journal15d
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
WuXi 2269-1.25%decrease; red down pointing triangle Biologics agreed to sell an overseas ... will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it ...
Reuters17d
China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom
Jan 6 (Reuters) - China's WuXi Biologics (2269.HK), opens new tab said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co (MRK.N), opens new tab for about $500 ...
Bloomberg L.P.16d
WuXi Bio to Sell Vaccine Facility to Merck for $500 Million
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate ...